Last reviewed · How we verify
Pulmicort Turbohaler — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Pulmicort Turbohaler (Pulmicort Turbohaler) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pulmicort Turbohaler TARGET | Pulmicort Turbohaler | AstraZeneca | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pulmicort Turbohaler CI watch — RSS
- Pulmicort Turbohaler CI watch — Atom
- Pulmicort Turbohaler CI watch — JSON
- Pulmicort Turbohaler alone — RSS
Cite this brief
Drug Landscape (2026). Pulmicort Turbohaler — Competitive Intelligence Brief. https://druglandscape.com/ci/pulmicort-turbohaler. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab